I agree that this site is using cookies. You can find further informations here.
X
Yamaguchi, Teppei
196  results:
Search for persons X
?
1

First-line nivolumab plus ipilimumab with or without chemot..:

Imai, Hisao ; Kijima, Takashi ; Azuma, Koichi...
Japanese Journal of Clinical Oncology.  54 (2024)  4 - p. 452-462 , 2024
Link: https://doi.org/10.1093/..
 
?
2

Efficacy of chemotherapy plus immune checkpoint inhibitors ..:

Yamaguchi, Teppei ; Shimizu, Junichi ; Matsuzawa, Reiko...
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Unrealistic expectations and disclosure of incurability in ..:

Hasegawa, Takaaki ; Okuyama, Toru ; Uemura, Takehiro...
Supportive Care in Cancer.  32 (2024)  7 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
4

Candidate tumor-specific CD8+T cell subsets identified in t..:

Sugita, Yusuke ; Muraoka, Daisuke ; Demachi-Okamura, Ayako...
OncoImmunology.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
5

EML4-ALK Variant 3a/b as a mechanism of osimertinib resista..:

Yamaguchi, Teppei ; Masago, Katsuhiro ; Sasaki, Eiichi...
Cancer Genetics.  280-281 (2024)  - p. 13-16 , 2024
Link: https://doi.org/10.1016/..
 
?
6

The incidence of drug-induced interstitial lung disease cau..:

Fujiwara, Yutaka ; Shimomura, Kazuhiro ; Yamaguchi, Teppei...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
7

Multicenter, Retrospective Study to Evaluate Necitumumab Pl..:

Murata, Yasunori ; Tanzawa, Shigeru ; Misumi, Toshihiro...
JTO Clinical and Research Reports.  4 (2023)  12 - p. 100593 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Elements of End-of-Life Discussions Associated With Patient..:

Hasegawa, Takaaki ; Okuyama, Toru ; Uemura, Takehiro...
The Oncologist.  29 (2023)  2 - p. e282-e289 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Efficacy and safety of second-line therapy of docetaxel plu..:

Matsuzawa, Reiko ; Morise, Masahiro ; Ito, Kentaro...
eClinicalMedicine.  66 (2023)  - p. 102303 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Liquid biopsy detects genomic drivers in NSCLC without EGFR..:

Uemura, Takehiro ; Kenmotsu, Hirotsugu ; Hazama, Daisuke...
Cancer Medicine.  12 (2023)  23 - p. 21097-21110 , 2023
Link: https://doi.org/10.1002/..
 
?
11

Prognostic Awareness and Discussions of Incurability in Pat..:

Hasegawa, Takaaki ; Okuyama, Toru ; Uemura, Takehiro...
The Oncologist.  27 (2022)  11 - p. 982-990 , 2022
Link: https://doi.org/10.1093/..
 
?
12

Risk factors for pneumonitis in patients with non‐small cel..:

Yamaguchi, Teppei ; Shimizu, Junichi ; Oya, Yuko...
Thoracic Cancer.  13 (2022)  5 - p. 724-731 , 2022
Link: https://doi.org/10.1111/..
 
?
13

Improvement of sep-CMA-ES for Optimization of High-Dimensio..:

, In: 2022 IEEE Symposium Series on Computational Intelligence (SSCI),
Yamaguchi, Teppei ; Uchida, Kento ; Shirakawa, Shinichi - p. 1659-1668 , 2022
Link: https://doi.org/10.1109/..
 
?
14

Drug-Induced Liver Injury in a Patient with Nonsmall Cell L..:

Yamaguchi, Teppei ; Shimizu, Junichi ; Oya, Yuko..
Case Reports in Oncology.  14 (2021)  2 - p. 886-891 , 2021
Link: https://doi.org/10.1159/..
 
?
15

Predictive risk factors for pneumothorax after transbronchi..:

Gotoh, Yusuke ; Yamaguchi, Teppei ; Yatsuya, Hiroshi...
BMC Pulmonary Medicine.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
1-15